Rydex Energy Services Inv
Rydex Energy Services Inv (RYVIX) Stock Competitors & Peer Comparison
See (RYVIX) competitors and their performances in Stock Market.
Peer Comparison Table: Asset Management Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| RYVIX | $314.15 | +1.05% | 6.3M | N/A | N/A | N/A |
| VITSX | $165.65 | +0.38% | 2.1T | 26.79 | $6.15 | +1.32% |
| VTSAX | $165.62 | +0.38% | 2.1T | 26.79 | $6.15 | +1.10% |
| PMFLX | $10.24 | -0.10% | 2T | N/A | N/A | N/A |
| OAKI | $26.67 | -0.01% | 1.6T | N/A | N/A | +0.04% |
| VOO | $629.53 | +0.00% | 1.5T | 27.79 | $22.81 | +1.12% |
| VFFSX | $338.71 | +0.43% | 1.5T | 27.60 | $12.19 | N/A |
| VFINX | $638.80 | +0.43% | 1.5T | 27.60 | $22.99 | +1.19% |
| BCTK | $24.60 | +0.00% | 1.1T | 43.31 | $0.57 | N/A |
| IVV | $687.68 | +0.00% | 756.9B | 27.76 | $24.94 | +1.16% |
Stock Comparison
RYVIX vs VITSX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, VITSX has a market cap of 2.1T. Regarding current trading prices, RYVIX is priced at $314.15, while VITSX trades at $165.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas VITSX's P/E ratio is 26.79. In terms of profitability, RYVIX's ROE is N/A, compared to VITSX's ROE of +0.00%. Regarding short-term risk, RYVIX and VITSX have similar daily volatility (0.00).Check VITSX's competition here
RYVIX vs VTSAX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, VTSAX has a market cap of 2.1T. Regarding current trading prices, RYVIX is priced at $314.15, while VTSAX trades at $165.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas VTSAX's P/E ratio is 26.79. In terms of profitability, RYVIX's ROE is N/A, compared to VTSAX's ROE of +0.08%. Regarding short-term risk, RYVIX and VTSAX have similar daily volatility (0.00).Check VTSAX's competition here
RYVIX vs PMFLX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, PMFLX has a market cap of 2T. Regarding current trading prices, RYVIX is priced at $314.15, while PMFLX trades at $10.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas PMFLX's P/E ratio is N/A. In terms of profitability, RYVIX's ROE is N/A, compared to PMFLX's ROE of N/A. Regarding short-term risk, RYVIX and PMFLX have similar daily volatility (0.00).Check PMFLX's competition here
RYVIX vs OAKI Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, OAKI has a market cap of 1.6T. Regarding current trading prices, RYVIX is priced at $314.15, while OAKI trades at $26.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas OAKI's P/E ratio is N/A. In terms of profitability, RYVIX's ROE is N/A, compared to OAKI's ROE of +0.00%. Regarding short-term risk, RYVIX is less volatile compared to OAKI. This indicates potentially lower risk in terms of short-term price fluctuations for RYVIX.Check OAKI's competition here
RYVIX vs VOO Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, VOO has a market cap of 1.5T. Regarding current trading prices, RYVIX is priced at $314.15, while VOO trades at $629.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas VOO's P/E ratio is 27.79. In terms of profitability, RYVIX's ROE is N/A, compared to VOO's ROE of +0.00%. Regarding short-term risk, RYVIX is less volatile compared to VOO. This indicates potentially lower risk in terms of short-term price fluctuations for RYVIX.Check VOO's competition here
RYVIX vs VFFSX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, VFFSX has a market cap of 1.5T. Regarding current trading prices, RYVIX is priced at $314.15, while VFFSX trades at $338.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas VFFSX's P/E ratio is 27.60. In terms of profitability, RYVIX's ROE is N/A, compared to VFFSX's ROE of N/A. Regarding short-term risk, RYVIX and VFFSX have similar daily volatility (0.00).Check VFFSX's competition here
RYVIX vs VFINX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, VFINX has a market cap of 1.5T. Regarding current trading prices, RYVIX is priced at $314.15, while VFINX trades at $638.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas VFINX's P/E ratio is 27.60. In terms of profitability, RYVIX's ROE is N/A, compared to VFINX's ROE of +0.00%. Regarding short-term risk, RYVIX and VFINX have similar daily volatility (0.00).Check VFINX's competition here
RYVIX vs BCTK Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, BCTK has a market cap of 1.1T. Regarding current trading prices, RYVIX is priced at $314.15, while BCTK trades at $24.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas BCTK's P/E ratio is 43.31. In terms of profitability, RYVIX's ROE is N/A, compared to BCTK's ROE of +0.00%. Regarding short-term risk, RYVIX is less volatile compared to BCTK. This indicates potentially lower risk in terms of short-term price fluctuations for RYVIX.Check BCTK's competition here
RYVIX vs IVV Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, IVV has a market cap of 756.9B. Regarding current trading prices, RYVIX is priced at $314.15, while IVV trades at $687.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas IVV's P/E ratio is 27.76. In terms of profitability, RYVIX's ROE is N/A, compared to IVV's ROE of +0.00%. Regarding short-term risk, RYVIX is less volatile compared to IVV. This indicates potentially lower risk in terms of short-term price fluctuations for RYVIX.Check IVV's competition here
RYVIX vs FXAIX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, FXAIX has a market cap of 755.2B. Regarding current trading prices, RYVIX is priced at $314.15, while FXAIX trades at $240.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas FXAIX's P/E ratio is N/A. In terms of profitability, RYVIX's ROE is N/A, compared to FXAIX's ROE of N/A. Regarding short-term risk, RYVIX and FXAIX have similar daily volatility (0.00).Check FXAIX's competition here
RYVIX vs SPY Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, SPY has a market cap of 704.3B. Regarding current trading prices, RYVIX is priced at $314.15, while SPY trades at $684.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas SPY's P/E ratio is 27.76. In terms of profitability, RYVIX's ROE is N/A, compared to SPY's ROE of +0.00%. Regarding short-term risk, RYVIX is less volatile compared to SPY. This indicates potentially lower risk in terms of short-term price fluctuations for RYVIX.Check SPY's competition here
RYVIX vs VXUS Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, VXUS has a market cap of 613.3B. Regarding current trading prices, RYVIX is priced at $314.15, while VXUS trades at $82.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas VXUS's P/E ratio is 19.02. In terms of profitability, RYVIX's ROE is N/A, compared to VXUS's ROE of +0.00%. Regarding short-term risk, RYVIX is less volatile compared to VXUS. This indicates potentially lower risk in terms of short-term price fluctuations for RYVIX.Check VXUS's competition here
RYVIX vs VTIAX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, VTIAX has a market cap of 607.7B. Regarding current trading prices, RYVIX is priced at $314.15, while VTIAX trades at $44.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas VTIAX's P/E ratio is 18.80. In terms of profitability, RYVIX's ROE is N/A, compared to VTIAX's ROE of +0.00%. Regarding short-term risk, RYVIX and VTIAX have similar daily volatility (0.00).Check VTIAX's competition here
RYVIX vs VTSNX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, VTSNX has a market cap of 607.7B. Regarding current trading prices, RYVIX is priced at $314.15, while VTSNX trades at $179.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas VTSNX's P/E ratio is 18.80. In terms of profitability, RYVIX's ROE is N/A, compared to VTSNX's ROE of +0.00%. Regarding short-term risk, RYVIX and VTSNX have similar daily volatility (0.00).Check VTSNX's competition here
RYVIX vs VTPSX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, VTPSX has a market cap of 607.7B. Regarding current trading prices, RYVIX is priced at $314.15, while VTPSX trades at $179.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas VTPSX's P/E ratio is 18.80. In terms of profitability, RYVIX's ROE is N/A, compared to VTPSX's ROE of +0.00%. Regarding short-term risk, RYVIX and VTPSX have similar daily volatility (0.00).Check VTPSX's competition here
RYVIX vs VTI Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, VTI has a market cap of 582.5B. Regarding current trading prices, RYVIX is priced at $314.15, while VTI trades at $338.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas VTI's P/E ratio is 26.95. In terms of profitability, RYVIX's ROE is N/A, compared to VTI's ROE of +0.00%. Regarding short-term risk, RYVIX is less volatile compared to VTI. This indicates potentially lower risk in terms of short-term price fluctuations for RYVIX.Check VTI's competition here
RYVIX vs BMOP Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, BMOP has a market cap of 441.1B. Regarding current trading prices, RYVIX is priced at $314.15, while BMOP trades at $25.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas BMOP's P/E ratio is N/A. In terms of profitability, RYVIX's ROE is N/A, compared to BMOP's ROE of +0.00%. Regarding short-term risk, RYVIX is less volatile compared to BMOP. This indicates potentially lower risk in terms of short-term price fluctuations for RYVIX.Check BMOP's competition here
RYVIX vs QQQ Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, QQQ has a market cap of 415.4B. Regarding current trading prices, RYVIX is priced at $314.15, while QQQ trades at $603.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas QQQ's P/E ratio is 32.73. In terms of profitability, RYVIX's ROE is N/A, compared to QQQ's ROE of +0.00%. Regarding short-term risk, RYVIX is less volatile compared to QQQ. This indicates potentially lower risk in terms of short-term price fluctuations for RYVIX.Check QQQ's competition here
RYVIX vs VUG Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, VUG has a market cap of 355.3B. Regarding current trading prices, RYVIX is priced at $314.15, while VUG trades at $461.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas VUG's P/E ratio is 35.30. In terms of profitability, RYVIX's ROE is N/A, compared to VUG's ROE of +0.00%. Regarding short-term risk, RYVIX is less volatile compared to VUG. This indicates potentially lower risk in terms of short-term price fluctuations for RYVIX.Check VUG's competition here
RYVIX vs VIGAX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, VIGAX has a market cap of 351.1B. Regarding current trading prices, RYVIX is priced at $314.15, while VIGAX trades at $239.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas VIGAX's P/E ratio is 35.01. In terms of profitability, RYVIX's ROE is N/A, compared to VIGAX's ROE of +0.00%. Regarding short-term risk, RYVIX and VIGAX have similar daily volatility (0.00).Check VIGAX's competition here
RYVIX vs VIIIX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, VIIIX has a market cap of 338.5B. Regarding current trading prices, RYVIX is priced at $314.15, while VIIIX trades at $558.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas VIIIX's P/E ratio is 27.60. In terms of profitability, RYVIX's ROE is N/A, compared to VIIIX's ROE of +0.00%. Regarding short-term risk, RYVIX and VIIIX have similar daily volatility (0.00).Check VIIIX's competition here
RYVIX vs VINIX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, VINIX has a market cap of 337.6B. Regarding current trading prices, RYVIX is priced at $314.15, while VINIX trades at $558.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas VINIX's P/E ratio is 27.60. In terms of profitability, RYVIX's ROE is N/A, compared to VINIX's ROE of +0.00%. Regarding short-term risk, RYVIX and VINIX have similar daily volatility (0.00).Check VINIX's competition here
RYVIX vs VEA Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, VEA has a market cap of 291.3B. Regarding current trading prices, RYVIX is priced at $314.15, while VEA trades at $68.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas VEA's P/E ratio is 19.62. In terms of profitability, RYVIX's ROE is N/A, compared to VEA's ROE of +0.00%. Regarding short-term risk, RYVIX is less volatile compared to VEA. This indicates potentially lower risk in terms of short-term price fluctuations for RYVIX.Check VEA's competition here
RYVIX vs LACG Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, LACG has a market cap of 290.4B. Regarding current trading prices, RYVIX is priced at $314.15, while LACG trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas LACG's P/E ratio is N/A. In terms of profitability, RYVIX's ROE is N/A, compared to LACG's ROE of +0.00%. Regarding short-term risk, RYVIX and LACG have similar daily volatility (0.00).Check LACG's competition here
RYVIX vs VTMNX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, VTMNX has a market cap of 288.1B. Regarding current trading prices, RYVIX is priced at $314.15, while VTMNX trades at $22.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas VTMNX's P/E ratio is 19.40. In terms of profitability, RYVIX's ROE is N/A, compared to VTMNX's ROE of +0.00%. Regarding short-term risk, RYVIX and VTMNX have similar daily volatility (0.00).Check VTMNX's competition here
RYVIX vs VDIPX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, VDIPX has a market cap of 288B. Regarding current trading prices, RYVIX is priced at $314.15, while VDIPX trades at $34.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas VDIPX's P/E ratio is 19.40. In terms of profitability, RYVIX's ROE is N/A, compared to VDIPX's ROE of +0.00%. Regarding short-term risk, RYVIX and VDIPX have similar daily volatility (0.00).Check VDIPX's competition here
RYVIX vs VTMGX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, VTMGX has a market cap of 287.9B. Regarding current trading prices, RYVIX is priced at $314.15, while VTMGX trades at $22.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas VTMGX's P/E ratio is 19.39. In terms of profitability, RYVIX's ROE is N/A, compared to VTMGX's ROE of +0.00%. Regarding short-term risk, RYVIX and VTMGX have similar daily volatility (0.00).Check VTMGX's competition here
RYVIX vs RGAGX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, RGAGX has a market cap of 279.8B. Regarding current trading prices, RYVIX is priced at $314.15, while RGAGX trades at $79.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas RGAGX's P/E ratio is 29.22. In terms of profitability, RYVIX's ROE is N/A, compared to RGAGX's ROE of N/A. Regarding short-term risk, RYVIX and RGAGX have similar daily volatility (0.00).Check RGAGX's competition here
RYVIX vs GAFFX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, GAFFX has a market cap of 279.4B. Regarding current trading prices, RYVIX is priced at $314.15, while GAFFX trades at $79.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas GAFFX's P/E ratio is 29.21. In terms of profitability, RYVIX's ROE is N/A, compared to GAFFX's ROE of N/A. Regarding short-term risk, RYVIX and GAFFX have similar daily volatility (0.00).Check GAFFX's competition here
RYVIX vs AGTHX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, AGTHX has a market cap of 279.3B. Regarding current trading prices, RYVIX is priced at $314.15, while AGTHX trades at $79.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas AGTHX's P/E ratio is 29.20. In terms of profitability, RYVIX's ROE is N/A, compared to AGTHX's ROE of N/A. Regarding short-term risk, RYVIX and AGTHX have similar daily volatility (0.00).Check AGTHX's competition here
RYVIX vs GFFFX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, GFFFX has a market cap of 278.1B. Regarding current trading prices, RYVIX is priced at $314.15, while GFFFX trades at $79.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas GFFFX's P/E ratio is 29.21. In terms of profitability, RYVIX's ROE is N/A, compared to GFFFX's ROE of N/A. Regarding short-term risk, RYVIX and GFFFX have similar daily volatility (0.00).Check GFFFX's competition here
RYVIX vs GFAFX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, GFAFX has a market cap of 276.3B. Regarding current trading prices, RYVIX is priced at $314.15, while GFAFX trades at $78.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas GFAFX's P/E ratio is 29.20. In terms of profitability, RYVIX's ROE is N/A, compared to GFAFX's ROE of N/A. Regarding short-term risk, RYVIX and GFAFX have similar daily volatility (0.00).Check GFAFX's competition here
RYVIX vs AFMBX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, AFMBX has a market cap of 275.6B. Regarding current trading prices, RYVIX is priced at $314.15, while AFMBX trades at $38.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas AFMBX's P/E ratio is 27.24. In terms of profitability, RYVIX's ROE is N/A, compared to AFMBX's ROE of +0.13%. Regarding short-term risk, RYVIX and AFMBX have similar daily volatility (0.00).Check AFMBX's competition here
RYVIX vs RLBGX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, RLBGX has a market cap of 274.8B. Regarding current trading prices, RYVIX is priced at $314.15, while RLBGX trades at $39.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas RLBGX's P/E ratio is 27.24. In terms of profitability, RYVIX's ROE is N/A, compared to RLBGX's ROE of N/A. Regarding short-term risk, RYVIX and RLBGX have similar daily volatility (0.00).Check RLBGX's competition here
RYVIX vs ABALX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, ABALX has a market cap of 274.6B. Regarding current trading prices, RYVIX is priced at $314.15, while ABALX trades at $38.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas ABALX's P/E ratio is 27.24. In terms of profitability, RYVIX's ROE is N/A, compared to ABALX's ROE of +0.13%. Regarding short-term risk, RYVIX and ABALX have similar daily volatility (0.00).Check ABALX's competition here
RYVIX vs AMBFX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, AMBFX has a market cap of 274.6B. Regarding current trading prices, RYVIX is priced at $314.15, while AMBFX trades at $38.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas AMBFX's P/E ratio is 27.24. In terms of profitability, RYVIX's ROE is N/A, compared to AMBFX's ROE of N/A. Regarding short-term risk, RYVIX and AMBFX have similar daily volatility (0.00).Check AMBFX's competition here
RYVIX vs BALFX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, BALFX has a market cap of 274.6B. Regarding current trading prices, RYVIX is priced at $314.15, while BALFX trades at $38.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas BALFX's P/E ratio is 27.23. In terms of profitability, RYVIX's ROE is N/A, compared to BALFX's ROE of N/A. Regarding short-term risk, RYVIX and BALFX have similar daily volatility (0.00).Check BALFX's competition here
RYVIX vs RGABX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, RGABX has a market cap of 244.2B. Regarding current trading prices, RYVIX is priced at $314.15, while RGABX trades at $69.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas RGABX's P/E ratio is 29.17. In terms of profitability, RYVIX's ROE is N/A, compared to RGABX's ROE of N/A. Regarding short-term risk, RYVIX and RGABX have similar daily volatility (0.00).Check RGABX's competition here
RYVIX vs RGAAX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, RGAAX has a market cap of 239.7B. Regarding current trading prices, RYVIX is priced at $314.15, while RGAAX trades at $68.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas RGAAX's P/E ratio is 29.17. In terms of profitability, RYVIX's ROE is N/A, compared to RGAAX's ROE of N/A. Regarding short-term risk, RYVIX and RGAAX have similar daily volatility (0.00).Check RGAAX's competition here
RYVIX vs GFACX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, GFACX has a market cap of 233.3B. Regarding current trading prices, RYVIX is priced at $314.15, while GFACX trades at $66.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas GFACX's P/E ratio is 29.17. In terms of profitability, RYVIX's ROE is N/A, compared to GFACX's ROE of N/A. Regarding short-term risk, RYVIX and GFACX have similar daily volatility (0.00).Check GFACX's competition here
RYVIX vs VTV Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, VTV has a market cap of 227.7B. Regarding current trading prices, RYVIX is priced at $314.15, while VTV trades at $206.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas VTV's P/E ratio is 21.83. In terms of profitability, RYVIX's ROE is N/A, compared to VTV's ROE of +0.00%. Regarding short-term risk, RYVIX is less volatile compared to VTV. This indicates potentially lower risk in terms of short-term price fluctuations for RYVIX.Check VTV's competition here
RYVIX vs ODIDX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, ODIDX has a market cap of 217B. Regarding current trading prices, RYVIX is priced at $314.15, while ODIDX trades at $9.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas ODIDX's P/E ratio is N/A. In terms of profitability, RYVIX's ROE is N/A, compared to ODIDX's ROE of N/A. Regarding short-term risk, RYVIX and ODIDX have similar daily volatility (0.00).Check ODIDX's competition here
RYVIX vs GRAG Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, GRAG has a market cap of 216.4B. Regarding current trading prices, RYVIX is priced at $314.15, while GRAG trades at $10.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas GRAG's P/E ratio is N/A. In terms of profitability, RYVIX's ROE is N/A, compared to GRAG's ROE of +0.00%. Regarding short-term risk, RYVIX is less volatile compared to GRAG. This indicates potentially lower risk in terms of short-term price fluctuations for RYVIX.Check GRAG's competition here
RYVIX vs FCTDX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, FCTDX has a market cap of 214B. Regarding current trading prices, RYVIX is priced at $314.15, while FCTDX trades at $20.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas FCTDX's P/E ratio is N/A. In terms of profitability, RYVIX's ROE is N/A, compared to FCTDX's ROE of N/A. Regarding short-term risk, RYVIX and FCTDX have similar daily volatility (0.00).Check FCTDX's competition here
RYVIX vs VMCIX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, VMCIX has a market cap of 203.7B. Regarding current trading prices, RYVIX is priced at $314.15, while VMCIX trades at $83.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas VMCIX's P/E ratio is 23.68. In terms of profitability, RYVIX's ROE is N/A, compared to VMCIX's ROE of +0.00%. Regarding short-term risk, RYVIX and VMCIX have similar daily volatility (0.00).Check VMCIX's competition here
RYVIX vs VMCPX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, VMCPX has a market cap of 203.7B. Regarding current trading prices, RYVIX is priced at $314.15, while VMCPX trades at $410.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas VMCPX's P/E ratio is 23.68. In terms of profitability, RYVIX's ROE is N/A, compared to VMCPX's ROE of +0.00%. Regarding short-term risk, RYVIX and VMCPX have similar daily volatility (0.00).Check VMCPX's competition here
RYVIX vs VIMAX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, VIMAX has a market cap of 203.7B. Regarding current trading prices, RYVIX is priced at $314.15, while VIMAX trades at $376.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas VIMAX's P/E ratio is 23.68. In terms of profitability, RYVIX's ROE is N/A, compared to VIMAX's ROE of +0.00%. Regarding short-term risk, RYVIX and VIMAX have similar daily volatility (0.00).Check VIMAX's competition here
RYVIX vs VO Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, VO has a market cap of 203.3B. Regarding current trading prices, RYVIX is priced at $314.15, while VO trades at $303.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas VO's P/E ratio is 23.78. In terms of profitability, RYVIX's ROE is N/A, compared to VO's ROE of N/A. Regarding short-term risk, RYVIX is less volatile compared to VO. This indicates potentially lower risk in terms of short-term price fluctuations for RYVIX.Check VO's competition here
RYVIX vs MER-PK Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, MER-PK has a market cap of 196.6B. Regarding current trading prices, RYVIX is priced at $314.15, while MER-PK trades at $25.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas MER-PK's P/E ratio is N/A. In terms of profitability, RYVIX's ROE is N/A, compared to MER-PK's ROE of +0.05%. Regarding short-term risk, RYVIX is less volatile compared to MER-PK. This indicates potentially lower risk in terms of short-term price fluctuations for RYVIX.Check MER-PK's competition here
RYVIX vs AICCX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, AICCX has a market cap of 178.4B. Regarding current trading prices, RYVIX is priced at $314.15, while AICCX trades at $62.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas AICCX's P/E ratio is 27.68. In terms of profitability, RYVIX's ROE is N/A, compared to AICCX's ROE of N/A. Regarding short-term risk, RYVIX and AICCX have similar daily volatility (0.00).Check AICCX's competition here
RYVIX vs AIVSX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, AIVSX has a market cap of 178.3B. Regarding current trading prices, RYVIX is priced at $314.15, while AIVSX trades at $63.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas AIVSX's P/E ratio is 27.71. In terms of profitability, RYVIX's ROE is N/A, compared to AIVSX's ROE of N/A. Regarding short-term risk, RYVIX and AIVSX have similar daily volatility (0.00).Check AIVSX's competition here
RYVIX vs AICFX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, AICFX has a market cap of 178.3B. Regarding current trading prices, RYVIX is priced at $314.15, while AICFX trades at $63.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas AICFX's P/E ratio is 27.70. In terms of profitability, RYVIX's ROE is N/A, compared to AICFX's ROE of N/A. Regarding short-term risk, RYVIX and AICFX have similar daily volatility (0.00).Check AICFX's competition here
RYVIX vs RICBX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, RICBX has a market cap of 178.2B. Regarding current trading prices, RYVIX is priced at $314.15, while RICBX trades at $62.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas RICBX's P/E ratio is 27.68. In terms of profitability, RYVIX's ROE is N/A, compared to RICBX's ROE of N/A. Regarding short-term risk, RYVIX and RICBX have similar daily volatility (0.00).Check RICBX's competition here
RYVIX vs RICAX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, RICAX has a market cap of 178.2B. Regarding current trading prices, RYVIX is priced at $314.15, while RICAX trades at $62.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas RICAX's P/E ratio is 27.68. In terms of profitability, RYVIX's ROE is N/A, compared to RICAX's ROE of N/A. Regarding short-term risk, RYVIX and RICAX have similar daily volatility (0.00).Check RICAX's competition here
RYVIX vs GLD Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, GLD has a market cap of 176.2B. Regarding current trading prices, RYVIX is priced at $314.15, while GLD trades at $459.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas GLD's P/E ratio is -49.87. In terms of profitability, RYVIX's ROE is N/A, compared to GLD's ROE of +0.00%. Regarding short-term risk, RYVIX is less volatile compared to GLD. This indicates potentially lower risk in terms of short-term price fluctuations for RYVIX.Check GLD's competition here
RYVIX vs FCNTX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, FCNTX has a market cap of 175.4B. Regarding current trading prices, RYVIX is priced at $314.15, while FCNTX trades at $24.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas FCNTX's P/E ratio is N/A. In terms of profitability, RYVIX's ROE is N/A, compared to FCNTX's ROE of +0.00%. Regarding short-term risk, RYVIX and FCNTX have similar daily volatility (0.00).Check FCNTX's competition here
RYVIX vs FCNKX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, FCNKX has a market cap of 175.3B. Regarding current trading prices, RYVIX is priced at $314.15, while FCNKX trades at $24.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas FCNKX's P/E ratio is N/A. In terms of profitability, RYVIX's ROE is N/A, compared to FCNKX's ROE of N/A. Regarding short-term risk, RYVIX and FCNKX have similar daily volatility (0.00).Check FCNKX's competition here
RYVIX vs IEFA Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, IEFA has a market cap of 174.1B. Regarding current trading prices, RYVIX is priced at $314.15, while IEFA trades at $97.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas IEFA's P/E ratio is 19.46. In terms of profitability, RYVIX's ROE is N/A, compared to IEFA's ROE of N/A. Regarding short-term risk, RYVIX is less volatile compared to IEFA. This indicates potentially lower risk in terms of short-term price fluctuations for RYVIX.Check IEFA's competition here
RYVIX vs C-PN Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, C-PN has a market cap of 173.8B. Regarding current trading prices, RYVIX is priced at $314.15, while C-PN trades at $29.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas C-PN's P/E ratio is N/A. In terms of profitability, RYVIX's ROE is N/A, compared to C-PN's ROE of +0.07%. Regarding short-term risk, RYVIX is less volatile compared to C-PN. This indicates potentially lower risk in terms of short-term price fluctuations for RYVIX.Check C-PN's competition here
RYVIX vs VB Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, VB has a market cap of 171.1B. Regarding current trading prices, RYVIX is priced at $314.15, while VB trades at $278.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas VB's P/E ratio is 21.66. In terms of profitability, RYVIX's ROE is N/A, compared to VB's ROE of +0.00%. Regarding short-term risk, RYVIX is less volatile compared to VB. This indicates potentially lower risk in terms of short-term price fluctuations for RYVIX.Check VB's competition here
RYVIX vs VSCIX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, VSCIX has a market cap of 170.5B. Regarding current trading prices, RYVIX is priced at $314.15, while VSCIX trades at $133.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas VSCIX's P/E ratio is 21.59. In terms of profitability, RYVIX's ROE is N/A, compared to VSCIX's ROE of +0.00%. Regarding short-term risk, RYVIX and VSCIX have similar daily volatility (0.00).Check VSCIX's competition here
RYVIX vs BLK Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, BLK has a market cap of 169.7B. Regarding current trading prices, RYVIX is priced at $314.15, while BLK trades at $1,081.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas BLK's P/E ratio is 31.00. In terms of profitability, RYVIX's ROE is N/A, compared to BLK's ROE of +0.11%. Regarding short-term risk, RYVIX is less volatile compared to BLK. This indicates potentially lower risk in terms of short-term price fluctuations for RYVIX.Check BLK's competition here
RYVIX vs ANWPX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, ANWPX has a market cap of 166.7B. Regarding current trading prices, RYVIX is priced at $314.15, while ANWPX trades at $72.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas ANWPX's P/E ratio is 26.71. In terms of profitability, RYVIX's ROE is N/A, compared to ANWPX's ROE of N/A. Regarding short-term risk, RYVIX and ANWPX have similar daily volatility (0.00).Check ANWPX's competition here
RYVIX vs CFNAX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, CFNAX has a market cap of 166.6B. Regarding current trading prices, RYVIX is priced at $314.15, while CFNAX trades at $95.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas CFNAX's P/E ratio is 27.62. In terms of profitability, RYVIX's ROE is N/A, compared to CFNAX's ROE of N/A. Regarding short-term risk, RYVIX and CFNAX have similar daily volatility (0.00).Check CFNAX's competition here
RYVIX vs FINFX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, FINFX has a market cap of 166.5B. Regarding current trading prices, RYVIX is priced at $314.15, while FINFX trades at $95.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas FINFX's P/E ratio is 27.63. In terms of profitability, RYVIX's ROE is N/A, compared to FINFX's ROE of N/A. Regarding short-term risk, RYVIX and FINFX have similar daily volatility (0.00).Check FINFX's competition here
RYVIX vs RFNCX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, RFNCX has a market cap of 166.5B. Regarding current trading prices, RYVIX is priced at $314.15, while RFNCX trades at $95.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas RFNCX's P/E ratio is 27.61. In terms of profitability, RYVIX's ROE is N/A, compared to RFNCX's ROE of N/A. Regarding short-term risk, RYVIX and RFNCX have similar daily volatility (0.00).Check RFNCX's competition here
RYVIX vs ANCFX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, ANCFX has a market cap of 166.5B. Regarding current trading prices, RYVIX is priced at $314.15, while ANCFX trades at $95.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas ANCFX's P/E ratio is 27.62. In terms of profitability, RYVIX's ROE is N/A, compared to ANCFX's ROE of N/A. Regarding short-term risk, RYVIX and ANCFX have similar daily volatility (0.00).Check ANCFX's competition here
RYVIX vs AFIFX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, AFIFX has a market cap of 166.5B. Regarding current trading prices, RYVIX is priced at $314.15, while AFIFX trades at $95.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas AFIFX's P/E ratio is 27.62. In terms of profitability, RYVIX's ROE is N/A, compared to AFIFX's ROE of N/A. Regarding short-term risk, RYVIX and AFIFX have similar daily volatility (0.00).Check AFIFX's competition here
RYVIX vs RNPCX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, RNPCX has a market cap of 165.8B. Regarding current trading prices, RYVIX is priced at $314.15, while RNPCX trades at $69.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas RNPCX's P/E ratio is 26.70. In terms of profitability, RYVIX's ROE is N/A, compared to RNPCX's ROE of N/A. Regarding short-term risk, RYVIX and RNPCX have similar daily volatility (0.00).Check RNPCX's competition here
RYVIX vs FNPFX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, FNPFX has a market cap of 165.6B. Regarding current trading prices, RYVIX is priced at $314.15, while FNPFX trades at $72.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas FNPFX's P/E ratio is 26.72. In terms of profitability, RYVIX's ROE is N/A, compared to FNPFX's ROE of N/A. Regarding short-term risk, RYVIX and FNPFX have similar daily volatility (0.00).Check FNPFX's competition here
RYVIX vs RNPGX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, RNPGX has a market cap of 165.6B. Regarding current trading prices, RYVIX is priced at $314.15, while RNPGX trades at $72.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas RNPGX's P/E ratio is 26.72. In terms of profitability, RYVIX's ROE is N/A, compared to RNPGX's ROE of N/A. Regarding short-term risk, RYVIX and RNPGX have similar daily volatility (0.00).Check RNPGX's competition here
RYVIX vs NPFFX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, NPFFX has a market cap of 165.6B. Regarding current trading prices, RYVIX is priced at $314.15, while NPFFX trades at $71.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas NPFFX's P/E ratio is 26.70. In terms of profitability, RYVIX's ROE is N/A, compared to NPFFX's ROE of N/A. Regarding short-term risk, RYVIX and NPFFX have similar daily volatility (0.00).Check NPFFX's competition here
RYVIX vs FPMAX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, FPMAX has a market cap of 155.3B. Regarding current trading prices, RYVIX is priced at $314.15, while FPMAX trades at $10.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas FPMAX's P/E ratio is N/A. In terms of profitability, RYVIX's ROE is N/A, compared to FPMAX's ROE of N/A. Regarding short-term risk, RYVIX and FPMAX have similar daily volatility (0.00).Check FPMAX's competition here
RYVIX vs VWO Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, VWO has a market cap of 154.3B. Regarding current trading prices, RYVIX is priced at $314.15, while VWO trades at $57.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas VWO's P/E ratio is 17.58. In terms of profitability, RYVIX's ROE is N/A, compared to VWO's ROE of +0.00%. Regarding short-term risk, RYVIX is less volatile compared to VWO. This indicates potentially lower risk in terms of short-term price fluctuations for RYVIX.Check VWO's competition here
RYVIX vs VEMAX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, VEMAX has a market cap of 151.7B. Regarding current trading prices, RYVIX is priced at $314.15, while VEMAX trades at $48.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas VEMAX's P/E ratio is 17.32. In terms of profitability, RYVIX's ROE is N/A, compared to VEMAX's ROE of +0.00%. Regarding short-term risk, RYVIX and VEMAX have similar daily volatility (0.00).Check VEMAX's competition here
RYVIX vs AWSHX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, AWSHX has a market cap of 150.4B. Regarding current trading prices, RYVIX is priced at $314.15, while AWSHX trades at $67.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas AWSHX's P/E ratio is 26.27. In terms of profitability, RYVIX's ROE is N/A, compared to AWSHX's ROE of N/A. Regarding short-term risk, RYVIX and AWSHX have similar daily volatility (0.00).Check AWSHX's competition here
RYVIX vs RWMFX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, RWMFX has a market cap of 150.3B. Regarding current trading prices, RYVIX is priced at $314.15, while RWMFX trades at $67.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas RWMFX's P/E ratio is 26.28. In terms of profitability, RYVIX's ROE is N/A, compared to RWMFX's ROE of N/A. Regarding short-term risk, RYVIX and RWMFX have similar daily volatility (0.00).Check RWMFX's competition here
RYVIX vs FWMIX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, FWMIX has a market cap of 150.3B. Regarding current trading prices, RYVIX is priced at $314.15, while FWMIX trades at $67.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas FWMIX's P/E ratio is 26.28. In terms of profitability, RYVIX's ROE is N/A, compared to FWMIX's ROE of N/A. Regarding short-term risk, RYVIX and FWMIX have similar daily volatility (0.00).Check FWMIX's competition here
RYVIX vs CWMAX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, CWMAX has a market cap of 149.8B. Regarding current trading prices, RYVIX is priced at $314.15, while CWMAX trades at $67.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas CWMAX's P/E ratio is 26.27. In terms of profitability, RYVIX's ROE is N/A, compared to CWMAX's ROE of N/A. Regarding short-term risk, RYVIX and CWMAX have similar daily volatility (0.00).Check CWMAX's competition here
RYVIX vs WSHFX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, WSHFX has a market cap of 149.4B. Regarding current trading prices, RYVIX is priced at $314.15, while WSHFX trades at $66.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas WSHFX's P/E ratio is 26.27. In terms of profitability, RYVIX's ROE is N/A, compared to WSHFX's ROE of N/A. Regarding short-term risk, RYVIX and WSHFX have similar daily volatility (0.00).Check WSHFX's competition here
RYVIX vs WGIFX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, WGIFX has a market cap of 148B. Regarding current trading prices, RYVIX is priced at $314.15, while WGIFX trades at $75.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas WGIFX's P/E ratio is 24.49. In terms of profitability, RYVIX's ROE is N/A, compared to WGIFX's ROE of N/A. Regarding short-term risk, RYVIX and WGIFX have similar daily volatility (0.00).Check WGIFX's competition here
RYVIX vs WSHCX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, WSHCX has a market cap of 147B. Regarding current trading prices, RYVIX is priced at $314.15, while WSHCX trades at $65.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas WSHCX's P/E ratio is 26.24. In terms of profitability, RYVIX's ROE is N/A, compared to WSHCX's ROE of N/A. Regarding short-term risk, RYVIX and WSHCX have similar daily volatility (0.00).Check WSHCX's competition here
RYVIX vs RWMBX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, RWMBX has a market cap of 146.6B. Regarding current trading prices, RYVIX is priced at $314.15, while RWMBX trades at $65.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas RWMBX's P/E ratio is 26.25. In terms of profitability, RYVIX's ROE is N/A, compared to RWMBX's ROE of N/A. Regarding short-term risk, RYVIX and RWMBX have similar daily volatility (0.00).Check RWMBX's competition here
RYVIX vs BX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, BX has a market cap of 145.6B. Regarding current trading prices, RYVIX is priced at $314.15, while BX trades at $125.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas BX's P/E ratio is 31.25. In terms of profitability, RYVIX's ROE is N/A, compared to BX's ROE of +0.36%. Regarding short-term risk, RYVIX is less volatile compared to BX. This indicates potentially lower risk in terms of short-term price fluctuations for RYVIX.Check BX's competition here
RYVIX vs IEMG Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, IEMG has a market cap of 141.9B. Regarding current trading prices, RYVIX is priced at $314.15, while IEMG trades at $74.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas IEMG's P/E ratio is 18.07. In terms of profitability, RYVIX's ROE is N/A, compared to IEMG's ROE of +0.00%. Regarding short-term risk, RYVIX is less volatile compared to IEMG. This indicates potentially lower risk in terms of short-term price fluctuations for RYVIX.Check IEMG's competition here
RYVIX vs AGG Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, AGG has a market cap of 140.3B. Regarding current trading prices, RYVIX is priced at $314.15, while AGG trades at $100.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas AGG's P/E ratio is 128.71. In terms of profitability, RYVIX's ROE is N/A, compared to AGG's ROE of N/A. Regarding short-term risk, RYVIX is less volatile compared to AGG. This indicates potentially lower risk in terms of short-term price fluctuations for RYVIX.Check AGG's competition here
RYVIX vs AEPFX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, AEPFX has a market cap of 140.1B. Regarding current trading prices, RYVIX is priced at $314.15, while AEPFX trades at $64.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas AEPFX's P/E ratio is 20.64. In terms of profitability, RYVIX's ROE is N/A, compared to AEPFX's ROE of N/A. Regarding short-term risk, RYVIX and AEPFX have similar daily volatility (0.00).Check AEPFX's competition here
RYVIX vs AEGFX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, AEGFX has a market cap of 140.1B. Regarding current trading prices, RYVIX is priced at $314.15, while AEGFX trades at $64.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas AEGFX's P/E ratio is 20.63. In terms of profitability, RYVIX's ROE is N/A, compared to AEGFX's ROE of N/A. Regarding short-term risk, RYVIX and AEGFX have similar daily volatility (0.00).Check AEGFX's competition here
RYVIX vs RERHX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, RERHX has a market cap of 140.1B. Regarding current trading prices, RYVIX is priced at $314.15, while RERHX trades at $64.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas RERHX's P/E ratio is 20.64. In terms of profitability, RYVIX's ROE is N/A, compared to RERHX's ROE of N/A. Regarding short-term risk, RYVIX and RERHX have similar daily volatility (0.00).Check RERHX's competition here
RYVIX vs RERGX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, RERGX has a market cap of 139.6B. Regarding current trading prices, RYVIX is priced at $314.15, while RERGX trades at $65.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas RERGX's P/E ratio is 20.64. In terms of profitability, RYVIX's ROE is N/A, compared to RERGX's ROE of N/A. Regarding short-term risk, RYVIX and RERGX have similar daily volatility (0.00).Check RERGX's competition here
RYVIX vs AEPGX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, AEPGX has a market cap of 139.6B. Regarding current trading prices, RYVIX is priced at $314.15, while AEPGX trades at $65.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas AEPGX's P/E ratio is 20.63. In terms of profitability, RYVIX's ROE is N/A, compared to AEPGX's ROE of N/A. Regarding short-term risk, RYVIX and AEPGX have similar daily volatility (0.00).Check AEPGX's competition here
RYVIX vs SWPPX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, SWPPX has a market cap of 133.7B. Regarding current trading prices, RYVIX is priced at $314.15, while SWPPX trades at $17.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas SWPPX's P/E ratio is 27.58. In terms of profitability, RYVIX's ROE is N/A, compared to SWPPX's ROE of N/A. Regarding short-term risk, RYVIX and SWPPX have similar daily volatility (0.00).Check SWPPX's competition here
RYVIX vs VITAX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, VITAX has a market cap of 131B. Regarding current trading prices, RYVIX is priced at $314.15, while VITAX trades at $378.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas VITAX's P/E ratio is 34.23. In terms of profitability, RYVIX's ROE is N/A, compared to VITAX's ROE of +0.00%. Regarding short-term risk, RYVIX and VITAX have similar daily volatility (0.00).Check VITAX's competition here
RYVIX vs VGT Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, VGT has a market cap of 130.4B. Regarding current trading prices, RYVIX is priced at $314.15, while VGT trades at $734.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas VGT's P/E ratio is 34.38. In terms of profitability, RYVIX's ROE is N/A, compared to VGT's ROE of +0.00%. Regarding short-term risk, RYVIX is less volatile compared to VGT. This indicates potentially lower risk in terms of short-term price fluctuations for RYVIX.Check VGT's competition here
RYVIX vs IWF Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, IWF has a market cap of 128.5B. Regarding current trading prices, RYVIX is priced at $314.15, while IWF trades at $450.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas IWF's P/E ratio is 35.19. In terms of profitability, RYVIX's ROE is N/A, compared to IWF's ROE of N/A. Regarding short-term risk, RYVIX is less volatile compared to IWF. This indicates potentially lower risk in terms of short-term price fluctuations for RYVIX.Check IWF's competition here
RYVIX vs NAESX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, NAESX has a market cap of 128.5B. Regarding current trading prices, RYVIX is priced at $314.15, while NAESX trades at $133.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas NAESX's P/E ratio is 21.59. In terms of profitability, RYVIX's ROE is N/A, compared to NAESX's ROE of +0.00%. Regarding short-term risk, RYVIX and NAESX have similar daily volatility (0.00).Check NAESX's competition here
RYVIX vs FSKAX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, FSKAX has a market cap of 125.5B. Regarding current trading prices, RYVIX is priced at $314.15, while FSKAX trades at $189.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas FSKAX's P/E ratio is N/A. In terms of profitability, RYVIX's ROE is N/A, compared to FSKAX's ROE of N/A. Regarding short-term risk, RYVIX and FSKAX have similar daily volatility (0.00).Check FSKAX's competition here
RYVIX vs VTTHX Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, VTTHX has a market cap of 122.7B. Regarding current trading prices, RYVIX is priced at $314.15, while VTTHX trades at $28.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas VTTHX's P/E ratio is 22.68. In terms of profitability, RYVIX's ROE is N/A, compared to VTTHX's ROE of N/A. Regarding short-term risk, RYVIX and VTTHX have similar daily volatility (0.00).Check VTTHX's competition here
RYVIX vs VIG Comparison February 2026
RYVIX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYVIX stands at 6.3M. In comparison, VIG has a market cap of 121.7B. Regarding current trading prices, RYVIX is priced at $314.15, while VIG trades at $227.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYVIX currently has a P/E ratio of N/A, whereas VIG's P/E ratio is 26.18. In terms of profitability, RYVIX's ROE is N/A, compared to VIG's ROE of +0.00%. Regarding short-term risk, RYVIX is less volatile compared to VIG. This indicates potentially lower risk in terms of short-term price fluctuations for RYVIX.Check VIG's competition here